toggle visibility Search & Display Options

Select All    Deselect All
 | 
Citations
 | 
   print
Azoulay, M., Santos, F., Shenouda, G., Petrecca, K., Oweida, A., Guiot, M. C., et al. (2017). Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution. J Neurooncol, 132(3), 419–426.
toggle visibility
Bischof, J., Westhoff, M. - A., Wagner, J. E., Halatsch, M. - E., Trentmann, S., Knippschild, U., et al. (2017). Cancer stem cells: The potential role of autophagy, proteolysis, and cathepsins in glioblastoma stem cells. Tumour Biol, 39(3), 1010428317692227.
toggle visibility
Momeny, M., Moghaddaskho, F., Gortany, N. K., Yousefi, H., Sabourinejad, Z., Zarrinrad, G., et al. (2017). Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells. Sci Rep, 7, 44075.
toggle visibility
Celiku, O., Tandle, A., Chung, J. - Y., Hewitt, S. M., Camphausen, K., & Shankavaram, U. (2017). Computational analysis of the mesenchymal signature landscape in gliomas. BMC Med Genomics, 10(1), 13.
toggle visibility
Jensen, S. S., Petterson, S. A., Halle, B., Aaberg-Jessen, C., & Kristensen, B. W. (2017). Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo. BMC Cancer, 17(1), 178.
toggle visibility
Select All    Deselect All
 | 
Citations
 | 
   print